2024: A Stellar Year for the iGEM Space Initiative

2024 witnessed a number of space happenings – from meteor showers, supermoons and the heightened visibility of the aurora borealis, to colossal rocket launches, planetary missions, the first commercial spacewalk and the first sample return from the lunar far side. Yet, among the most exciting space happenings were the accomplishments of the iGEM Space Initiative. 

Empowering genetic designers to build the future

Asimov has teamed up with iGEM once again to empower the genetic designers who are building the future – you – the iGEMers who are building new solutions with biology for the 2024 Competition. As a platinum partner for 2024, we are thrilled to give back to the community that has helped inspire, support, and connect students with each other to make synthetic biology the technology that will transform the world.

In Conversation with Eric Herrera, CEO - Maverick Biometals | Interviews with Biofounders: From a Baltimore Bench to a 10,000 sq. ft. biotech lab - Maverick BioMetals is Pioneering BioMining Solutions

Meet Eric Herrera, the co-founder and CEO of Maverick Biometals, a finalist in the 2022 iGEM Startup Showcase in 2022 and Y Combinator S22 Cohort. Eric shared his remarkable entrepreneurship journey, starting with a single bench in a Baltimore basement to a 10,000 sq. ft. biotechnology laboratory. With a team of scientists from over 10 countries, Maverick Biometals is pioneering the production of lithium batteries and silicon semiconductors entirely through biological methods

2024 Insights: iGEM Alumni Startups Funding Trends and SynBio x AI Innovations

2024 has been an incredible year for iGEM Startups, marked by notable funding trends among iGEM Alumni startups, particularly at the intersection of artificial intelligence (AI) and synthetic biology (SynBio) within our ecosystem. This year alone, seven alumni startups have secured over $95 million in funding—from government grants to multimillion-dollar investments—highlighting the scalability and market potential of these groundbreaking technologies.

In Conversation with the Co-Founder of Granza Bio — From Lab Partners to Biofounders: How a Chance Collaboration Built Granza Bio

Ashwin Jainarayanan is a biofounder with a deep-rooted passion for advancing medical science through synthetic biology and immuno-oncology. Ashwin's journey of founding Granza Bio began during his PhD at the University of Oxford, when a serendipitous email mix-up connected him with Ashwin Nandakumar, who was working on another project at a nearby department.